Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 103 | 90 | 97 | 97 | 130 |
| Accounts receivable | -12 | 7 | -2 | 56 | -50 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -59 | N/A |
| Other Working Capital | 142 | 30 | -30 | -4 | 103 |
| Other Operating Activity | -407 | -281 | -324 | -414 | -664 |
| Operating Cash Flow | $-175 | $-154 | $-260 | $-325 | $-481 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -1 | 0 | -5 | 0 |
| Investing Cash Flow | $0 | $-1 | $0 | $-5 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -160 | -79 | -75 | -70 | -86 |
| Common Stock Issued | 0 | 0 | 0 | 603 | N/A |
| Other Financing Activity | 273 | 207 | 131 | -221 | 770 |
| Financing Cash Flow | $113 | $128 | $56 | $312 | $684 |
| Beginning Cash Position | 134 | 161 | 365 | 383 | 179 |
| End Cash Position | 72 | 134 | 161 | 365 | 383 |
| Net Cash Flow | $-62 | $-27 | $-204 | $-18 | $203 |
| Free Cash Flow | |||||
| Operating Cash Flow | -175 | -154 | -260 | -325 | -481 |
| Capital Expenditure | 0 | -1 | N/A | -5 | N/A |
| Free Cash Flow | -175 | -155 | -260 | -330 | -481 |